Online Only Articles

A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe Francophone des Myelodysplasies (GFM)

Service d’Hématologie Séniors, St Louis Hospital, University Paris 7
Hematology Department, Hopital d’Adultes du Brabois, Nancy
Centre Hospitalier d’Annecy
Hematology Department, CH de l’Archet, Nice
Service d’Hématologie Séniors, St Louis Hospital, University Paris 7
Hematologie Clinique, CHU Avicenne, Bobigny
Department of Hematology, Nantes University Hospital
Department of Statistics (DBIM), Hôpital Saint Louis University Paris 7, France
Department of Statistics (DBIM), Hôpital Saint Louis University Paris 7, France
Service d’Hématologie Séniors, St Louis Hospital, University Paris 7
Vol. 104 No. 4 (2019): April, 2019 https://doi.org/10.3324/haematol.2018.203885